Most healthcare practice transactions fail for predictable reasons. The deals that fall apart — or close and then unravel operationally — almost always have one of three problems: an insurance enrollment mess nobody planned for, a purchase price disconnected from reality, or revenue that can’t survive the transition to lawful operation.

Here’s what to watch for.

1. Insurance Enrollment and Credentialing Are Not the Same Problem — and Both Can Sink You

When ownership of a healthcare practice changes, insurance reimbursement does not transfer automatically. The incoming provider must enroll with each payer independently, and in many cases must also complete credentialing — a separate process in which the payer verifies the provider’s qualifications before approving participation.

These two processes have different timelines, different requirements, and different points of failure. Enrollment can take weeks to months depending on the payer. Credentialing, particularly with Medicare, Medicaid, or large commercial carriers, can take longer. If either process stalls, the practice cannot bill — and a practice that cannot bill cannot pay its staff, its rent, or its lender.

The seller’s cooperation is often the deciding variable. Sellers who disengage after signing, become unresponsive to payer inquiries, or refuse to assist with the documentation these processes require can cause significant reimbursement gaps for the buyer. A seller unwilling to cooperate with payer transition before closing is not a negotiating posture — it’s a serious operational warning.

Buyers should assess the seller’s cooperative intent early and build transition assistance obligations into the purchase agreement. The contract should specify what cooperation is required, for how long, and what happens if the seller doesn’t deliver.

2. Value Is Determined by the Market, Not by the Seller

Valuation is not a seller’s prerogative — it’s a market outcome. Both parties need to understand this before the negotiation starts.

In private practice healthcare transactions, valuation typically begins with rule-of-thumb methods: a multiple of gross collections, an EBITDA multiple, or some combination of both. Formal appraisals and valuation professionals can add analytical rigor and provide a defensible starting point. But a formal valuation is just that — a starting point. What the practice is actually worth is whatever a qualified buyer is willing to pay and a lender is willing to finance.

That last piece matters more than most sellers want to hear. In practice, the ceiling on purchase price in a financed transaction is often set by the lender, not the parties. If the deal doesn’t cash flow at a given price — meaning the practice’s revenue cannot service the acquisition debt while supporting the buyer’s compensation — the financing doesn’t work, and the deal doesn’t close at that number.

Market conditions shape everything else. A practice in a desirable location with strong demand and multiple interested buyers will command top dollar. In that environment, sellers are unlikely to absorb adjustments for aging equipment or dated tenant improvements — buyers competing for the asset will accept those conditions to win the deal. The inverse is equally true: a practice in a weak market with limited buyer interest will be hit hard for every deferred capital item. Outdated imaging, worn-out operatories, and neglected infrastructure become negotiating leverage when demand is thin.

Sellers need to internalize one reality: the practice sells for what someone is willing to pay, not what the seller believes it is worth. Anchoring to a number the market won’t support — because the financing doesn’t work, because no buyer sees the value, or because comparable transactions don’t justify it — produces deals that fall apart or never get started.

Buyers have a different obligation. Different buyers value the same practice differently based on their financial position, their growth strategy, and what they intend to do with the asset. A buyer acquiring their first practice values it differently than a group adding a sixth location. Neither framework is wrong — but buyers should identify their own valuation parameters clearly and hold to them. Paying outside your own framework because a seller is pushing a number, or because competitive pressure makes it feel necessary, is how buyers end up overleveraged on day one.

The market sets the price. Both parties do better when they accept that early.

3. If the Revenue Isn’t Sustainable, You’re Not Buying a Practice — You’re Buying a Liability

Some practices report revenue that cannot survive the transition to new ownership. That gap between reported performance and sustainable performance is one of the most dangerous problems in a healthcare acquisition — and one of the most frequently overlooked.

The most common version of this problem is improper billing. Upcoding, unbundling, billing under incorrect provider credentials, and submitting claims for services not delivered as documented all inflate a practice’s apparent revenue. When the conduct stops — because the new owner operates lawfully — the revenue drops. The buyer is then servicing acquisition debt against a practice that never actually performed at the level the purchase price assumed.

This problem is not limited to insurance-based practices. Cash-pay and fee-for-service businesses — including many dental offices and veterinary hospitals — carry their own version of this risk. If the seller’s revenue depends on aggressive upselling, high-pressure treatment recommendations, or a sales culture the buyer is unwilling or unable to replicate, the buyer may be acquiring a materially less valuable business than the financials suggest. The revenue was real; it just wasn’t repeatable under different ownership.

Due diligence should directly address this question. Billing records, payer correspondence, prior audits, and any history of overpayment demands or repayment agreements are all relevant. If a practice’s revenue appears inconsistent with its patient volume, procedure mix, or staffing level, that discrepancy requires a specific explanation before closing — not an assumption that the numbers are fine.

The legal exposure adds another layer. Under the False Claims Act (31 U.S.C. § 3729), liability attaches to any person or entity that knowingly submits false claims to a federal payer, including Medicare and Medicaid. An asset purchase structure does not automatically extinguish that exposure. Federal courts applying the substantial continuity doctrine have held that a buyer who continues operating an acquired practice — same location, same staff, same payer relationships — can face liability for the seller’s pre-closing conduct, particularly where the buyer had notice of potential billing problems before closing. The DOJ has taken an aggressive position on this point, though courts are not uniform in how they apply it. Buyers cannot assume a clean break simply because the deal was structured as an asset purchase.

If the revenue requires conduct the buyer won’t continue, the purchase price needs to reflect what the practice will actually produce — not what it has historically reported.

These issues are not obscure. They appear in healthcare practice transactions regularly, and the buyers and sellers who handle them well treat them as non-negotiable due diligence items from the start — not problems to solve after the deal closes.

Morgan Advisory Group represents healthcare professionals and investors in practice acquisitions, partnership structures, and healthcare platform development. To discuss a potential transaction, contact the firm to schedule a consultation.